Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection

Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers

NCT01292174 ·Status: COMPLETED ·Phase: PHASE1

A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease

NCT00205231 ·Status: COMPLETED ·Phase: NA

A Study of the Safety and Antiretroviral Activity of 3BNC117

NCT02588586 ·Status: COMPLETED ·Phase: PHASE2

Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders

NCT01817283 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection

NCT00001036 ·Status: COMPLETED ·Phase: PHASE1

Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452

NCT00006495 ·Status: COMPLETED ·Phase: PHASE1

Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals

NCT00955006 ·Status: COMPLETED ·Phase: PHASE1

Twins Study of Gene Therapy for HIV Infection

NCT00001535 ·Status: COMPLETED ·Phase: PHASE1

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

NCT00002359 ·Status: COMPLETED ·Phase: PHASE3

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

NCT00001353 ·Status: COMPLETED

Dipyridamole for Immune Activation in HIV

NCT02121756 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART

NCT02225665 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

NCT00001445 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells

NCT00000822 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines

NCT01264445 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3

NCT00000756 ·Status: COMPLETED ·Phase: PHASE1

Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection

NCT01666990 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults

NCT01140126 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Vaccine in Adults With HIV

NCT00195234 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

NCT00131560 ·Status: UNKNOWN ·Phase: PHASE2

A Study of 1592U89 in HIV-Infected Adults

NCT00002200 ·Status: COMPLETED ·Phase: NA

Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts

NCT00001319 ·Status: COMPLETED

Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects

NCT00706550 ·Status: COMPLETED ·Phase: NA

A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART

NCT00002392 ·Status: COMPLETED ·Phase: NA

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

NCT00119873 ·Status: COMPLETED ·Phase: PHASE1